These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20733003)

  • 1. Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.
    Lennerz JK; Hurov JB; White LS; Lewandowski KT; Prior JL; Planer GJ; Gereau RW; Piwnica-Worms D; Schmidt RE; Piwnica-Worms H
    Mol Cell Biol; 2010 Nov; 30(21):5043-56. PubMed ID: 20733003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo.
    Hurov JB; Huang M; White LS; Lennerz J; Choi CS; Cho YR; Kim HJ; Prior JL; Piwnica-Worms D; Cantley LC; Kim JK; Shulman GI; Piwnica-Worms H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5680-5. PubMed ID: 17372192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
    Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
    Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.
    Liu W; Singh R; Choi CS; Lee HY; Keramati AR; Samuel VT; Lifton RP; Shulman GI; Mani A
    J Biol Chem; 2012 Mar; 287(10):7213-23. PubMed ID: 22232553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fat diet induced adiposity and insulin resistance in mice lacking the myotonic dystrophy protein kinase.
    Llagostera E; Carmona MC; Vicente M; Escorihuela RM; Kaliman P
    FEBS Lett; 2009 Jun; 583(12):2121-5. PubMed ID: 19482024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Par-1/MARK family of protein kinases: from polarity to metabolism.
    Hurov J; Piwnica-Worms H
    Cell Cycle; 2007 Aug; 6(16):1966-9. PubMed ID: 17721078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity.
    Sun C; Tian L; Nie J; Zhang H; Han X; Shi Y
    J Biol Chem; 2012 Nov; 287(45):38305-15. PubMed ID: 22992738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
    Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
    Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
    Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
    Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice.
    Neschen S; Morino K; Hammond LE; Zhang D; Liu ZX; Romanelli AJ; Cline GW; Pongratz RL; Zhang XM; Choi CS; Coleman RA; Shulman GI
    Cell Metab; 2005 Jul; 2(1):55-65. PubMed ID: 16054099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation.
    Chakravarthy MV; Zhu Y; Yin L; Coleman T; Pappan KL; Marshall CA; McDaniel ML; Semenkovich CF
    J Lipid Res; 2009 Apr; 50(4):630-40. PubMed ID: 19029118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CTRP1 disrupts glucose and lipid homeostasis.
    Rodriguez S; Lei X; Petersen PS; Tan SY; Little HC; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E678-E697. PubMed ID: 27555298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity.
    Gao J; He J; Zhai Y; Wada T; Xie W
    J Biol Chem; 2009 Sep; 284(38):25984-92. PubMed ID: 19617349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adropin deficiency is associated with increased adiposity and insulin resistance.
    Ganesh Kumar K; Zhang J; Gao S; Rossi J; McGuinness OP; Halem HH; Culler MD; Mynatt RL; Butler AA
    Obesity (Silver Spring); 2012 Jul; 20(7):1394-402. PubMed ID: 22318315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
    Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
    Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance.
    Shi SY; Martin RG; Duncan RE; Choi D; Lu SY; Schroer SA; Cai EP; Luk CT; Hopperton KE; Domenichiello AF; Tang C; Naples M; Dekker MJ; Giacca A; Adeli K; Wagner KU; Bazinet RP; Woo M
    J Biol Chem; 2012 Mar; 287(13):10277-10288. PubMed ID: 22275361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of SPAK kinase reduces body weight gain in mice fed a high-fat diet by improving energy expenditure and insulin sensitivity.
    Torre-Villalvazo I; Cervantes-Pérez LG; Noriega LG; Jiménez JV; Uribe N; Chávez-Canales M; Tovar-Palacio C; Marfil-Garza BA; Torres N; Bobadilla NA; Tovar AR; Gamba G
    Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E53-E65. PubMed ID: 29066461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance.
    Kang HS; Okamoto K; Kim YS; Takeda Y; Bortner CD; Dang H; Wada T; Xie W; Yang XP; Liao G; Jetten AM
    Diabetes; 2011 Jan; 60(1):177-88. PubMed ID: 20864514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
    Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
    J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.